Access summary

access-summary

access-information

21-0505

Field work was undertaken by Heritage staff in support of Energy, Mines and Resources Land application 2020-7081. Seeking access to the report arising from those field activities. Timeframe: September 1, 2020 - December 24, 2021

21-0370

Scientific evidence supporting the lifting of covid 19 restrictions and rational for keeping restrictions lifted. Vaccination status of covid 19 positive cases. Expected end date for vaccine mandate. Timeframe: July 1, 2021 - October 31, 2021.

21-0492

Date: When did YTG and/or Dept of Health first notify the public that the covid vaccines that that are administering are waning and/or are expected to continue to wane. Requested: Dated documents and/or emails and/or meeting minutes. Timeframe: January 1, 2021 - December 17, 2021

21-0469

YTG acknowledges that covid vaccines do not prevent infection. YTG acknowledges that covid vaccines do not prevent transmission. YTG acknowledges that the covid vaccine efficacy wanes in a few months. YTG acknowledges that boosters are being used to prop up falling antibodies in the vaccinated without any mid- to long-term data on adverse effects of the vaccines.

21-0416

Number of positive COVID-19 cases recorded among both students and teachers in Yukon schools since the beginning of the 2021-22 school year. Breakdown of positive cases of both students and teachers by school since the beginning of the 2021-22 school year.
Timeframe: September 1, 2021 - November 17, 2021
ADDITIONAL INFORMATION:

21-0452

A list of employees (including chief medical officers) and their relative formal education post graduate degrees in Virology Epidemiology Transmission of infectious diseases Transmission of viruses Oversight experience in any phase 1, phase 2, phase 3 formal clinical trials in drugs, drug therapies, vaccines, mRNA vaccines, control of transmissabilty of infectious diseases and viruses. Timeframe: December 1, 2019 - November 15, 2021

21-0449

Common colds are among the most common illnesses. Many different viruses (common colds are caused by various rhinoviruses, coronaviruses, adenoviruses) have no vaccine.
What's the prior scientific validation (longterm clinical trials, and peer-reviewed, replicated studies) of using and/or mandating experimental mRNA vaccines for a virus that's never had a successful vaccine to combat any mutating coronaviruses causing any respiratory illness or disease? Timeframe: December 1, 2019 - December 1, 2021

21-0455

YTG/Department of Health administered mRNA vaccine from Moderna since the start of the vaccine rollout about a year ago. It's common knowledge that there can be serious, life threatening and even fatal adverse reactions to all covid mRNA vaccines. My understanding it that adverse health effects are noticeably higher in 2nd doses vs 1st doses. Logic would dictate that risk of adverse health effects would only increase with subsequent doses.

21-0453

Staff involved in advising and/or recommending facemask restrictions (including chief medical officers) Their formal degrees and/or years of experience in the specialized fields of virology, epidemiology, transmission and/or prevention of transmission of infectious diseases, transmission of viruses and/or prevention of transmission of viruses.

21-0456

Heart inflammation is a known risk from mRNA vaccines European Medicines Agency (BBC report) https://www.bbc.com/news/health-57781637 "The link with heart inflammation was found only in the vaccines that rely on mRNA technology to train the immune system. There was no link found for vaccines such as Oxford-AstraZeneca or Janssen, which use a genetically modified virus. However, the EMA has advised anyone with a history of capillary leak syndrome should not be given the Janssen vaccine.